This latest fundraising brings Minakara's total amount raised to 1 billion yen. Going forward, the company will work on the development of central pharmacies (collective dispensing and distribution facilities) for the era of online medical care, the planning and development of pharmaceuticals developed jointly with pharmaceutical manufacturers (private brand pharmaceuticals), and support for the D2C development, sales promotion, and marketing of pharmaceutical manufacturers themselves.
About minacolor

Service URL:https://minacolor.com/
minacolor is an online pharmacy where users can purchase medicines with correct knowledge. Just as in offline pharmacies, value is provided all the way from knowing the right medicine for one's symptoms from the information held by pharmacists and pharmacists, to purchasing via Internet payment (*1), and then to medication management.
The company currently offers 800 SKUs of products centered on medicines, including over-the-counter ("OTC") drugs and other private products developed independently with pharmaceutical manufacturers, and proposes the most appropriate medicine for the patient's symptoms.
They are popular with patients who are too sick to purchase medicines in stores and with those who are raising children and have difficulty going out.
What you can do with Minacara
- examine Get pharmacist-supervised medical information
- choose Choose the right drug for you from a wide range of OTC drugs
- Buy Now Online purchase of OTC drugs
- Consult with us Free chat consultation with a pharmacist
1 Each drug is sold in accordance with the regulations of the drug category.
Online Pharmacy" is Minacara's goal

Minakara operates with the mission of "delivering self-care that is right for each and every person. The self-care we want to deliver is attracting a great deal of national attention, as evidenced by the introduction of the self-medication tax system.
And it is medicines and pharmacists that play a major role in self-care, and as a first step, Minakara is working to resolve this issue.
In the current Japanese healthcare system, there are many cases in which people are required to take OTC drugs at their own discretion. A survey conducted by the Advertising Bureau of the Asahi Shimbun's Tokyo Head Office (*2) also found that 71.61 TP3T have a tendency to use OTC drugs as a way to deal with colds, stiff shoulders, and other physical ailments for which they can determine symptoms themselves.
In addition, due in part to the impact of the new coronavirus, the demand for online drug purchases continues to increase year after year (*3). On the other hand, there are challenges in getting patients to take their medications with the correct information due to the following issues.
・OTC drugs are being converted to e-commerce, and drugs are getting into patients' hands without pharmacist's advice.
As a result of the flood of information on the Internet, it is unclear which information is correct and which information matches.
As a result of advertising and promotional effects of drugs, people choose drugs based on their impressions rather than on their symptoms.
Minakara aims to solve these issues and create an online pharmacy that helps consumers obtain health with correct knowledge of both prescription and OTC drugs.
2 JSMI - What to do when you feel sick 2008
https://www.jsmi.jp/reserch/asahi/0803.pdf
※3 2018年から2019年にかけて0.2%EC化率が向上(出典:経済産業省)
https://www.meti.go.jp/policy/it_policy/statistics/outlook/r1_kohyoshiryo.pdf
Funding Background
With the lifting of the ban on online sales of first-line drugs in 2014 and the major legal reform trend of the self-medication tax system in 2018, online sales of pharmaceuticals have attracted a lot of attention.
In addition, Minacara has been developing and selling private brand drugs in collaboration with pharmaceutical manufacturers since 2018. Compared to the sale of existing products, private brands are more beneficial to both pharmaceutical manufacturers and patients in terms of enhanced after-sales support and the ability to utilize EC data.
The market background and the results of the current services provided have led to this fundraising. With the procured funds, the company will promote the recruitment of human resources and other activities to provide more people with opportunities to use the company as an online pharmacy in cooperation with many pharmaceutical manufacturers.
Funding Summary
Past funding underwriters are listed below.
- incubate fund
- STRIVE
- Spiral Innovation Partners
- AG Capital
- Graduate School of Management, Globis University
- Kaigen Pharma
- Japan Medic
- Chiba Dojo
- Mr. Keisuke Honda, professional soccer player and private investor
Underwriter's Comment
Hiroshi Oka, Managing Partner, Spiral Innovation Partners
We believe that the environment surrounding healthcare and pharmaceuticals is undergoing rapid and irreversible changes, such as the Corona Disaster and the promotion of self-medication.
We are convinced that Minakara is at the center of this revolution and has the power to revolutionize the overall distribution of medicines, from manufacturing to delivery to consumers. I have high expectations for the drug distribution revolution that Minakara will bring about.
Shuzo Ueki, Associate, Spiral Innovation Partners
In Japan, where the birthrate is declining and the population is aging rapidly, reducing medical costs by promoting self-medication is an urgent issue.
We are convinced that MINAKARA, with its excellent members including Mr. Kina, can solve this issue by eliminating the asymmetry of information in the purchase of pharmaceuticals, and have decided to invest in the company.
By accelerating collaboration with the Seino Group, the Fund's anchor LP, we will contribute to the growth of Minakara's business and ultimately improve the patient experience by transforming pharmaceutical logistics.
Mr. Yusuke Murata, Managing Partner, Incubate Fund
In the past six months, the field of medicine and dispensing has changed dramatically, and social issues related to delivery methods and information asymmetry have become much more apparent.
We have been accompanying Minakara since its inception, and there has never been a more important time to question our existence than now, so we have once again made an additional investment.
Mr. Ryo Taneichi, Associate, Incubate Fund
We have seen the market grow since the ban on online sales of OTC drugs was lifted in 2013 through the efforts of Kenko.com and Rakuten, and we feel that Corona has greatly improved the importance of self-medication and opened up the market.
We will do our best to support Minacara's efforts to create an "online pharmacy" experience similar to that of a store pharmacy online.
Mr. Tatsuo Tsutsumi, Managing Partner, STRIVE
We invested in Minacara Kina as we did last time, hoping to work together to realize Minacara Kina's vision of implementing "the next standard for everyday medical care.
One of the challenges facing Japanese society is how to optimize the ever-increasing cost of medical care, and one solution lies in reforming routine medical care, which is exactly the direction in which Minakara is heading.
We look forward to Minakara's continued growth.
Ms. Natsumi Negishi, Partner, STRIVE
Minakara is a unique team with a mix of pharmacists and engineers, and we have witnessed their passion and speed from the time of investment.
The company has been developing data-driven pharmacy services and products on the strength of its ability to capture data on customer preferences and needs that are difficult to capture in real stores, and we expect that this procurement will further accelerate DX in the OTC drug industry.
Masami Yamada, Director of Investment, Asahi Media Lab Ventures
Minakara has been involved not only in the sale of over-the-counter drugs, but also in their manufacture and distribution, online provision of information, free consultation with pharmacists, and post-purchase support, with the aim of realizing a world where all patients can take the right medicine for their symptoms.
| name of company | Minakara Corporation |
| Establishment | November 2013 |
| Location | SD Bldg. 4F, 3-18-3 Uchikanda, Chiyoda-ku, Tokyo 101-0047, Japan |
| representative | Shinya Kina |
| Business Overview | Operation of online pharmacy "Minakara |
| uniform resouce locator | https://about.minacolor.com/ Inquiry form for pharmaceutical manufacturers and users: voice@minacolor.co.jp https://about.minacolor.com/contact/ |








